Measurement and Validation of the COmprehensive Score for financial Toxicity (COST) in a Population With Diabetes.

Minal R Patel,Guanghao Zhang,Michele Heisler,Peter X K Song,John D Piette,Xu Shi,Hae Mi Choe,Alyssa Smith,Kenneth Resnicow

Diabetes care（2022）

引用 9|浏览12

暂无评分

摘要

Findings support both the reliability and validity of the COST-FACIT among adults with diabetes and high A1C levels. More research is needed to support the use of the COST-FACIT tool as a clinically relevant patient-centered instrument for diabetes care.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要